| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |